Abstract
To report the electrophysiological findings in patients with unilateral optic neuritis (ON), with particular reference to the electroretinogram (ERG). A retrospective analysis of full-field ERG, pattern ERG (PERG) and pattern visual evoked potential findings from 46 patients with clinical and electrophysiological findings in keeping with unilateral ON. ISCEV standard ERGs did not significantly differ between the optic neuritis and fellow eyes, nor between patients with and without MS. Differences were present in the N95 component of the PERG, which was significantly lower in the affected eye, and the pattern reversal visual evoked potential, which showed significantly longer peak time (latency) in the affected eye. In addition, there was a significant difference between patients with and without multiple sclerosis (MS). No significant inter-ocular asymmetry in ISCEV standard ERGs was present in these cases of unilateral optic neuritis, either as a clinically isolated syndrome or as part of multiple sclerosis. All ERGs recorded were normal.
Similar content being viewed by others
References
Halliday AM, McDonald WI, Mushin J (1972) Delayed visual evoked response in optic neuritis. Lancet 1:982–985
Halliday AM, McDonald WI, Mushin J (1973) Visual evoked response in diagnosis of multiple sclerosis. Br Med J (Clin Res Ed) 4:661–664
Holder G (1991) Multiple sclerosis. In: Heckenlively JR, Arden G (eds) Principles and practice of clinical elecrophysiology of vision. Mosby Year Book, St Louis, pp 797–805
Holder GE, Gale RP, Acheson JF, Robson AG (2009) Electrodiagnostic assessment in optic nerve disease. Curr Opin Neurol 22:3–10
Lightman S, McDonald WI, Bird AC, Francis DA, Hoskins A, Batchelor JR, Halliday AM (1987) Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain 110:405–414
Forooghian F, Sproule M, Westall C, Gordon L, Jirawuthiworavong G, Shimazaki K, O’Connor P (2006) Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol 113:123–132
Gills JP Jr (1966) Electroretinographic abnormalities and advanced multiple sclerosis. Invest Ophthalmol 5(6):555–559
Feinsod M, Auerbach E (1969) Changes in the electroretinogram (ERG) in lesions of the optic nerve. Electroencephalogr Clin Neurophysiol 27:217
Feinsod M, Rowe H, Auerbach E (1971) Changes in the electroretinogram in patients with optic nerve lesions. Doc Ophthalmol 29:169–200
Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR, Savino PJ, Guy JR, Trobe JD, McCrary JA III, Smith CH, Chrousos GA, Thompson HS, Katz BJ, Brodsky MC, Goodwin JA, Atwell CW, the Optic Neuritis Study Group* (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 326:581–588
Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118:69–77
Holder GE, Brigell MG, Hawlina M, Meigen T, Vaegan, Bach M (2007) ISCEV standard for clinical pattern electroretinography–2007 update. Doc Ophthalmol 114:111–116
Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Tormene AP, Vaegan (2010) ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol 120:111–119
Falsini B, Bardocci A, Porciatti V, Bolzani R, Piccardi M (1992) Macular dysfunction in multiple sclerosis revealed by steady-state flicker and pattern ERGs. Electroencephalogr Clin Neurophysiol 82:53–59
Papakostopoulos D, Fotiou F, Hart JC, Banerji NK (1989) The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol 74:1–10
Fotiou F, Koutlas E, Tsorlinis I, Dimitriades A, Fountoulakis K, Tsiptsios I, Sitzoglou K, Karampatakis V, Stangos N (1999) The value of neurophysiological and MRI assessment in demyelinating optic neuritis (DON). Electromyogr Clin Neurophysiol 39:397–404
Feinsod M, Rowe H, Auerbach E (1971) Enhanced retinal responses without signs of optic nerve involvement. Doc Ophthalmol 29:201–211
Holder GE (1987) Significance of abnormal pattern electroretinography in anterior visual pathway dysfunction. Br J Ophthalmol 71:166–171
Ryan S, Arden GB (1988) Electrophysiological discrimination between retinal and optic nerve disorders. Doc Ophthalmol 68:247–255
Viswanathan S, Frishman LJ, Robson JG (2000) The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity. Invest Ophthalmol Vis Sci 41:2797–2810
Holder GE (2004) Electrophysiological assessment of optic nerve disease. Eye (Lond) 18:1133–1143
Holder GE (2001) Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res 20:531–561
Gotoh Y, Machida S, Tazawa Y (2004) Selective loss of the photopic negative response in patients with optic nerve atrophy. Arch Ophthalmol 122:341–346
Nakamura H, Miyamoto K, Yokota S, Ogino K, Yoshimura N (2011) Focal macular photopic negative response in patients with optic neuritis. Eye (Lond) 25:358–364
Holder GE (1991) The incidence of abnormal pattern electroretinography in optic nerve demyelination. Electroencephalogr Clin Neurophysiol 78:18–26
Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, Oakley JD, Durbin MK, Meyer SA, Balcer LJ, Frohman EM, Rosenzweig JM, Newsome SD, Ratchford JN, Nguyen QD, Calabresi PA (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134:518–533
Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9:921–932
Lamirel C, Newman NJ, Biousse V (2010) Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis. Rev Neurol (Paris) 166:978–986
Heidary G, Rizzo JF 3rd (2010) Use of optical coherence tomography to evaluate papilledema and pseudopapilledema. Semin Ophthalmol 25:198–205
Savini G, Carbonelli M, Barboni P (2011) Spectral-domain optical coherence tomography for the diagnosis and follow-up of glaucoma. Curr Opin Ophthalmol 22:115–123
Parisi V (2003) Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s disease. Semin Ophthalmol 18:50–57
Klistorner A, Arvind H, Garrick R, Graham SL, Paine M, Yiannikas C (2010) Interrelationship of optical coherence tomography and multifocal visual-evoked potentials after optic neuritis. Invest Ophthalmol Vis Sci 51:2770–2777
Almarcegui C, Dolz I, Pueyo V, Garcia E, Fernandez FJ, Martin J, Ara JR, Honrubia F (2010) Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients. Neurophysiol Clin 40:129–135
The Optic Neuritis Study Group (1997) Visual function 5 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 115:1545–1552
Acknowledgments
We wish to thank the consultant neuro-ophthalmologists: Dr Gordon Plant, Mr James Acheson and Dr Ahmed Toosey. CF acknowledges the support of the Sydney Eye Hospital Alumni Travelling Fellowship award and the Royal Australian and New Zealand College of Ophthalmologists Eye Foundation Fellowship award. GEH acknowledges funding from the Foundation Fighting Blindness (USA) and the Alcon Research Institute. Also acknowledged is support from the Department of Health (UK) through an award made by the National Institute for Health Research to the Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fraser, C.L., Holder, G.E. Electroretinogram findings in unilateral optic neuritis. Doc Ophthalmol 123, 173–178 (2011). https://doi.org/10.1007/s10633-011-9294-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10633-011-9294-x